A-384 Development of a sensitive, quantitative C-peptide immunoassay on a dry-printed carbon nanotube electrochemical sensor
The C-peptide immunoassay built on CNT-based electrochemical sensors is capable of highly sensitive and robust quantification of C-peptide from patient urine samples and has the potential to be the core technology of a point-of-care diagnostic, which would improve patient outcomes and reduce health care costs.